636 related articles for article (PubMed ID: 15241631)
1. Fluorinated tracers for imaging cancer with positron emission tomography.
Couturier O; Luxen A; Chatal JF; Vuillez JP; Rigo P; Hustinx R
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1182-206. PubMed ID: 15241631
[TBL] [Abstract][Full Text] [Related]
2. [Fluorinated analogs of nucleosides and fluorinated tracers of gene expression for positron emission tomography].
Couturier O; Chatal JF; Hustinx R
Bull Cancer; 2004 Sep; 91(9):695-703. PubMed ID: 15544995
[TBL] [Abstract][Full Text] [Related]
3. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):50-65. PubMed ID: 18235421
[TBL] [Abstract][Full Text] [Related]
4. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
5. Radiochemical synthesis of 2'-[18F]-labelled and 3'-[18F]-labelled nucleosides for positron emission tomography imaging.
Meyer JP; Probst KC; Westwell AD
J Labelled Comp Radiopharm; 2014 May; 57(5):333-7. PubMed ID: 24692121
[TBL] [Abstract][Full Text] [Related]
6. Fluorinated amino acids for tumour imaging with positron emission tomography.
Laverman P; Boerman OC; Corstens FH; Oyen WJ
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):681-90. PubMed ID: 11976809
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and preliminary in vivo evaluation of new [
Collet C; Schmitt S; Maskali F; Clément A; Chrétien F; Karcher G; Marie PY; Poussier S; Lamandé-Langle S
Bioorg Med Chem; 2017 Oct; 25(20):5603-5612. PubMed ID: 28893600
[TBL] [Abstract][Full Text] [Related]
8. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated PET Tracers for Molecular Imaging of σ
Weber F; Brust P; Laurini E; Pricl S; Wünsch B
Adv Exp Med Biol; 2017; 964():31-48. PubMed ID: 28315263
[TBL] [Abstract][Full Text] [Related]
10. PET tracers in musculoskeletal disease beyond FDG.
Wieder HA; Pomykala KL; Benz MR; Buck AK; Herrmann K
Semin Musculoskelet Radiol; 2014 Apr; 18(2):123-32. PubMed ID: 24715445
[TBL] [Abstract][Full Text] [Related]
11. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
12. Non FDG PET.
Nanni C; Fantini L; Nicolini S; Fanti S
Clin Radiol; 2010 Jul; 65(7):536-48. PubMed ID: 20541653
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging (PET) of brain tumors.
Basu S; Alavi A
Neuroimaging Clin N Am; 2009 Nov; 19(4):625-46. PubMed ID: 19959009
[TBL] [Abstract][Full Text] [Related]
14. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
Gulyás B; Halldin C
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
[TBL] [Abstract][Full Text] [Related]
15. Applications of PET imaging of neurological tumors with radiolabeled amino acids.
Galldiks N; Langen KJ
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):70-82. PubMed ID: 25517079
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid.
McConathy J; Martarello L; Malveaux EJ; Camp VM; Simpson NE; Simpson CP; Bowers GD; Olson JJ; Goodman MM
J Med Chem; 2002 May; 45(11):2240-9. PubMed ID: 12014962
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Preliminary Evaluation of an
Murakami Y; Fujita Y; Fushiki H
Mol Imaging Biol; 2023 Jun; 25(3):495-502. PubMed ID: 36220956
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, radiolabelling and initial biological characterisation of
Pretze M; Neuber C; Kinski E; Belter B; Köckerling M; Caflisch A; Steinbach J; Pietzsch J; Mamat C
Org Biomol Chem; 2020 Apr; 18(16):3104-3116. PubMed ID: 32253415
[TBL] [Abstract][Full Text] [Related]
19. 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins.
de Bruin B; Kuhnast B; Hinnen F; Yaouancq L; Amessou M; Johannes L; Samson A; Boisgard R; Tavitian B; Dollé F
Bioconjug Chem; 2005; 16(2):406-20. PubMed ID: 15769096
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
